Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Metzinger

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Biomed Research International|July 30, 2015
miR-126 Is Involved in Vascular Remodeling under Laminar Shear StressAna Mondadori dos Santos, Laurent Metzinger, Oualid Haddad, et al.
Plos One|October 25, 2012
Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223Ashraf Yusuf Rangrez, Eléonore M'Baya-Moutoula, Valérie Metzinger-Le Meuth, et al.
International Journal of Molecular Sciences|May 7, 2025
Quantification of Urine and Plasma Levels of Extracellular Vesicles in a Cohort of Kidney Transplant Recipients and Chronic Kidney Disease PatientsValentine Jacob, Quentin de Berny, François Brazier, et al.
Current Vascular Pharmacology|July 10, 2019
Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured CarotidsEleonore M'baya-Moutoula, Alexandre Marchand, Isabelle Six, et al.
Clinical Kidney Journal|August 31, 2017
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary studyBenjamin Brigant, Valérie Metzinger-Le Meuth, Ziad A Massy, et al.
Non-Coding RNA Research|June 9, 2025
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemiaEmma Brisot, Pierre-Marie Leprêtre, Eya Hamza, et al.
Clinical Kidney Journal|June 24, 2017
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary studyBenjamin Brigant, Valérie Metzinger-Le Meuth, Ziad A Massy, et al.
Biochimica Et Biophysica Acta|October 22, 2013
Possible involvement of microRNAs in vascular damage in experimental chronic kidney diseaseFatiha Taïbi, Valérie Metzinger-Le Meuth, Eléonore M'Baya-Moutoula, et al.
Scientific Reports|March 16, 2019
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patientsOphélie Fourdinier, Eva Schepers, Valérie Metzinger-Le Meuth, et al.
Journal of Cellular and Molecular Medicine|June 12, 2021
miR-126-3p is essential for CXCL12-induced angiogenesisKévin Bassand, Laurent Metzinger, Meriem Naïm, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Biomed Research International|July 30, 2015
miR-126 Is Involved in Vascular Remodeling under Laminar Shear StressAna Mondadori dos Santos, Laurent Metzinger, Oualid Haddad, et al.
Plos One|October 25, 2012
Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223Ashraf Yusuf Rangrez, Eléonore M'Baya-Moutoula, Valérie Metzinger-Le Meuth, et al.
International Journal of Molecular Sciences|May 7, 2025
Quantification of Urine and Plasma Levels of Extracellular Vesicles in a Cohort of Kidney Transplant Recipients and Chronic Kidney Disease PatientsValentine Jacob, Quentin de Berny, François Brazier, et al.
Current Vascular Pharmacology|July 10, 2019
Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured CarotidsEleonore M'baya-Moutoula, Alexandre Marchand, Isabelle Six, et al.
Clinical Kidney Journal|August 31, 2017
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary studyBenjamin Brigant, Valérie Metzinger-Le Meuth, Ziad A Massy, et al.
Non-Coding RNA Research|June 9, 2025
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemiaEmma Brisot, Pierre-Marie Leprêtre, Eya Hamza, et al.
Clinical Kidney Journal|June 24, 2017
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary studyBenjamin Brigant, Valérie Metzinger-Le Meuth, Ziad A Massy, et al.
Biochimica Et Biophysica Acta|October 22, 2013
Possible involvement of microRNAs in vascular damage in experimental chronic kidney diseaseFatiha Taïbi, Valérie Metzinger-Le Meuth, Eléonore M'Baya-Moutoula, et al.
Scientific Reports|March 16, 2019
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patientsOphélie Fourdinier, Eva Schepers, Valérie Metzinger-Le Meuth, et al.
Journal of Cellular and Molecular Medicine|June 12, 2021
miR-126-3p is essential for CXCL12-induced angiogenesisKévin Bassand, Laurent Metzinger, Meriem Naïm, et al.
Pageof 5